Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLCN2 | P51788 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.34 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.33 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9413635 | 0.82 | ADRA2B (0.44) | CLCN2ADRA2BADRA2CLIPGHDAC3 | |
| SCHEMBL4840068 | 0.77 | DAO (0.33) | DAOADRA2BADRA2CGABRA1GABRB2 | |
| SCHEMBL30358479 | 0.71 | KCNH2 (0.38) | DAOADRA2BADRA2CGABRA1GABRB2 | |
| SCHEMBL11353390 | 0.71 | CYP3A4 (0.51) | LIPGPTGS2HDAC3HDAC4HDAC1 | |
| SCHEMBL23937092 | 0.70 | CLCN2 (0.45) | CLCN2ADRA2BADRA2CPTGS2GRM5 | |
| SCHEMBL2255093 | 0.69 | ALDH1A1 (0.53) | CLCN2GABRA1GABRB2HDAC3HDAC4 | |
| SCHEMBL13813554 | 0.69 | ADRA2B (0.46) | CLCN2ADRA2BADRA2CPTGS2GRM5 | |
| SCHEMBL22448900 | 0.68 | CLCN2 (0.43) | CLCN2ADRA2BADRA2CPTGS2 | |
| SCHEMBL674691 | 0.68 | GABRA1 (0.64) | DAOGABRA1GABRB2PTGS2 | |
| SCHEMBL1135151 | 0.67 | ADRA2B (0.45) | ADRA2BADRA2CPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090032768-A1 | WATER-SOLUBLE PHENYLENEDIAMINE COMPOSITIONS AND METHODS FOR STABILIZING ETHYLENICALLY UNSATURATED COMPOUNDS AND MONOMERS | GENERAL ELECTRIC COMPANY (US) | 2009-02-05 | — | — | US | disclosed |
| US-7414162-B2 | For inhibiting polymerization of ethylenically unsaturated monomers; includes a water-soluble phenylenediamine composition | GENERAL ELECTRIC COMPANY (US) | 2008-08-19 | — | — | US | disclosed |
| US-20070187649-A1 | Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers | GENERAL ELECTRIC COMPANY | 2007-08-16 | — | — | US | disclosed |
| US-20040211702-A1 | Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers | GENERAL ELECTRIC COMPANY | 2004-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070187649-A1 | Water-soluble phenylenediamine compositions and methods for stabilizing ethylenically unsaturated compounds and monomers | PNMT, EPN1, FASN | CLCN2 3441/4885DAO 1125/4885ADRA2B 2606/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.